These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2468198)

  • 1. Association of CD7 and CD3 molecules on the T cell surface.
    Sandrin MS; Vaughan HA; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):103-4. PubMed ID: 2468198
    [No Abstract]   [Full Text] [Related]  

  • 2. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
    Suthanthiran M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
    [No Abstract]   [Full Text] [Related]  

  • 3. Requirements for primary T cell activation.
    Melton LB; Lakkis FG; Deloria D; Williams JW; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):331-2. PubMed ID: 2978906
    [No Abstract]   [Full Text] [Related]  

  • 4. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

  • 5. Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.
    Gebel HM; Lebeck LL; Jensik SC; Landay AL; Bray RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1745-6. PubMed ID: 2523590
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of expression of CD2, CD3, and T cell antigen receptor molecules during early human fetal thymic development.
    Haynes BF; Singer KH; Denning SM; Martin ME
    J Immunol; 1988 Dec; 141(11):3776-84. PubMed ID: 2903194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.
    Henell KR; Bakke A; Kenny TA; Kimball JA; Barry JM; Norman DJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1070-1. PubMed ID: 1824886
    [No Abstract]   [Full Text] [Related]  

  • 8. Difficulties and new strategies in the identification of functional T cell populations in humans.
    Moretta A; Mingari MC; Pantaleo G; Melioli G; Moretta L
    Monogr Allergy; 1983; 18():106-11. PubMed ID: 6417476
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.
    Hafler DA; Chofflon M; Benjamin D; Dang NH; Breitmeyer J
    J Immunol; 1989 Apr; 142(8):2590-6. PubMed ID: 2564857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 11. T cell activation by monoclonal antibodies: an approach to study principles of immunoregulation.
    Meuer SC; Schraven B; Möbius U
    Transplant Proc; 1988 Apr; 20(2):269-72. PubMed ID: 2834837
    [No Abstract]   [Full Text] [Related]  

  • 12. Accessory cell signals need not be species restricted in xenogeneic activation.
    Uren S; Bolcevic Z; Hwang LR; Boyle W
    Transplant Proc; 1992 Feb; 24(1):208-10. PubMed ID: 1531709
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a functional T-cell population by the use of surface markers: present limitations and new strategies.
    Mingari MC; Moretta A; Pantaleo G; Moretta L
    Ann Immunol (Paris); 1982; 133D(2):147-53. PubMed ID: 6819808
    [No Abstract]   [Full Text] [Related]  

  • 14. T cell receptor/CD3 negative variants are unresponsive to stimulation through the Ly-6 encoded molecule, TAP.
    Bamezai A; Reiser H; Rock KL
    J Immunol; 1988 Sep; 141(5):1423-8. PubMed ID: 2842394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of murine thymocytes with CD3-associated T-cell receptor structures.
    Bluestone JA; Pardoll D; Sharrow SO; Fowlkes BJ
    Nature; 1987 Mar 5-11; 326(6108):82-4. PubMed ID: 3102972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antibodies to CD3 surface antigen and phytohemagglutinin-mediated T cellular responses by inhibiting Ca2+/phospholipid-dependent protein kinase activity with the aid of 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride.
    Nel AE; Schabort I; Rheeder A; Bouic P; Wooten MW
    J Immunol; 1987 Oct; 139(7):2230-6. PubMed ID: 2821109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD7 is associated with CD3 and CD45 on human T cells.
    Lazarovits AI; Osman N; Le Feuvre CE; Ley SC; Crumpton MJ
    J Immunol; 1994 Nov; 153(9):3956-66. PubMed ID: 7523512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose.
    Colonna JO; Millis JM; Martello J; Levy P; Iwaki Y; Brems JJ; Klein AS; Hiatt JR; Busuttil RW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2247-8. PubMed ID: 2523600
    [No Abstract]   [Full Text] [Related]  

  • 19. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies.
    Manger B; Weiss A; Imboden J; Laing T; Stobo JD
    J Immunol; 1987 Oct; 139(8):2755-60. PubMed ID: 3116093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.